Original InvestigationClinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Under an Elsevier user license
open archive
Central Illustration
Key Words
genotype
late gadolinium enhancement
left ventricular ejection fraction
major adverse cardiovascular events
noncompaction cardiomyopathy
physiologic hypertrabeculation
Abbreviations and Acronyms
CI
confidence interval
CMR
cardiovascular magnetic resonance
DCM
dilated cardiomyopathy
ECG
electrocardiogram
HF
heart failure
HR
hazard ratio
ICD
implantable cardioverter-defibrillator
LGE
late gadolinium enhancement
LV
left ventricular
LVEF
left ventricular ejection fraction
LVNC
left ventricular noncompaction
MACE
major adverse cardiovascular events
NCCM
noncompaction cardiomyopathy
SCD
sudden cardiac death
SE
systemic embolism
TTE
transthoracic echocardiography
VA
ventricular arrhythmia
VF
ventricular fibrillation
VT
ventricular tachycardia
Cited by (0)
Javed Butler, MD, MPH, MBA, served as Guest Editor-in-Chief for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 by the American College of Cardiology Foundation. Published by Elsevier.